A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy
Wass, Maxi, Göllner, Stefanie, Besenbeck, Birgit, Schlenk, Richard F., Mundmann, Petra, Göthert, Joachim R., Noppeney, Richard, Schliemann, Christoph, Mikesch, Jan-Henrik, Lenz, Georg, Dugas, MartinJournal:
Leukemia
DOI:
10.1038/s41375-020-0892-z
Date:
June, 2020
Fichier:
PDF, 1.73 MB
2020
File converter
Plus de résultats de recherche
More benefits 
